CASSANDRA CARNEVALE: Open Payments
NPI 1760909063 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 10 payments from 4 companies in 2025. Trend: 2023 $544 · 2024 $456 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $169 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| ABBVIE INC. | 2 | $60 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
Products named: AUSTEDO XR, REXULTI, VRAYLAR, INGREZZA, UZEDY.
Industry payments across NY — which companies pay providers there.
